Hypoxia and the extracellular matrix: drivers of tumour metastasis
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Of the deaths attributed to cancer, 90% are due to metastasis, and treatments that prevent or cure metastasis remain elusive. Emerging data indicate that hypoxia and the extracellular matrix (ECM) might have crucial roles in metastasis. During tumour evolution, changes in the composition and the overall content of the ECM reflect both its biophysical and biological properties and these strongly influence tumour and stromal cell properties, such as proliferation and motility. Originally thought of as independent contributors to metastatic spread, recent studies have established a direct link between hypoxia and the composition and the organization of the ECM, which suggests a new model in which multiple microenvironmental signals might converge to synergistically influence metastatic outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, secretion of hypoxia-inducible factors (HIFs) by tumor cells induces macrophage and fi broblast recruitment to hypoxic regions of the primary tumor, leading to increased ECM remodeling and angiogenesis [21].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vivo, stromal cells such as fibroblasts and endothelial cells do not remain statically embedded but actively reposition themselves in response to gradients in oxygen, nutrients, and soluble factors [274,275].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [274]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recently published literature discusses the role of the size of a tumor (and the associated hypoxia levels) on its aggressiveness [81,82,83,84,85] and on the efficacy of drug delivery to it [84,86,87].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedGilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 467
Self-citationRetractedZhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
Self-citationRetractedRETRACTED: Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis
Gilkes, D. M., Chaturvedi, P., Bajpai, S., Wong, C. C., Wei, H., Pitcairn, S., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3963 · Cited by 296
Self-citationRetractedProcollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis
Gilkes, D. M., Bajpai, S., Wong, C. C., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0629 · Cited by 252
Self-citationRetractedGilkes, D. M., Xiang, L., Lee, S. J., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321510111 · Cited by 184
Self-citationRetractedMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Cited by
Items 201–300 of 1,001
Xu, Q., Zhang, Y., Yang, Z., Jiang, G., Lv, M., Wang, H., Liu, C., Xie, J., Wang, C., Guo, K., et al. (2022) · Theranostics · doi:10.7150/thno.73039 · Cited by 91
“As we all known, hypoxia, as another characteristic feature of TME, is a barrier to tumor therapy and responsible for tumor migration, invasion, metastasis, and resistance [38-41].”
BackgroundDaxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
Lin, C.-W., Wang, L.-K., Wang, S.-P., Chang, Y.-L., Wu, Y.-Y., Chen, H.-Y., Hsiao, T.-H., Lai, W.-Y., Lu, H.-H., Chang, Y.-H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13867 · Cited by 86
Perron, G., Jandaghi, P., Solanki, S., Safisamghabadi, M., Storoz, C., Karimzadeh, M., Papadakis, A. I., Arseneault, M., Scélo, G., Banks, R. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.031 · Cited by 100
Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
Ingangi, V., Minopoli, M., Ragone, C., Motti, M. L., & Carriero, M. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00082 · Cited by 91
Wang, H., Wang, L., Zhou, X., Luo, X., Liu, K., Jiang, E., Chen, Y., Shao, Z., & Shang, Z. (2020) · BioMed Research International · doi:10.1155/2020/2125656 · Cited by 86
Li, M., Wang, J., Wang, C., Xia, L., Xu, J., Xie, X., & Lü, W. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112153 · Cited by 97
Beyond energy storage: roles of glycogen metabolism in health and disease
Zhang, H., Ma, J., Tang, K., & Huang, B. (2020) · FEBS Journal · doi:10.1111/febs.15648 · Cited by 89
Liu, Y., Niu, R., Deng, R., Wang, Y., Song, S., & Zhang, H. (2023) · Advanced Materials · doi:10.1002/adma.202307752 · Cited by 87
Emerging Topics on Disseminated Cancer Cell Dormancy and the Paradigm of Metastasis
Aguirre-Ghiso, J. A., & Sosa, M. S. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050446 · Cited by 85
Janji, B., Berchem, G., & Chouaïb, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00887 · Cited by 88
Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review
Yayan, J., Franke, K.-J., Berger, M. P., Windisch, W., & Rasche, K. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-08920-5 · Cited by 100
“Likewise, more twist-related protein 1 (TWIST1) can be found in the metastatic tumor cells [25, 26 ] (Fig.”
BackgroundWSB1 promotes tumor metastasis by inducing pVHL degradation
Kim, J. J., Lee, S. B., Jang, J., Yi, S.-Y., Kim, S.-H., Han, S.-A., Lee, J.-M., Tong, S.-Y., Vincelette, N. D., Gao, B., et al. (2015) · Genes & Development · doi:10.1101/gad.268128.115 · Cited by 83
Function of insulin‑like growth factor 1 receptor in cancer resistance to chemotherapy (Review)
Yuan, J., Yin, Z., Tao, K., Wang, G., & Gao, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.7276 · Cited by 92
Research progress on tumor hypoxia-associative nanomedicine
Xu, X., Chen, S., Yi, N.-B., Li, X., Chen, S., Lei, Z., Cheng, D., & Sun, T. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.003 · Cited by 87
Pan, Z., Bao, Y., Hu, M., Zhu, Y., Tan, C., Fan, L., Yu, H., Wang, A., Cui, J., & Sun, G. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01355-8 · Cited by 88
“At present, studies have shown that changes in extracellular matrix components are important regulatory nodes for cell migration and invasion [47].”
BackgroundCollective cancer cell invasion induced by coordinated contractile stresses
Valencia, A. M. J., Wu, P.-H., Yogurtcu, O. N., Rao, P. P., DiGiacomo, J. W., Godet, I., He, L., Lee, M.-H., Gilkes, D. M., Sun, S. X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5874 · Cited by 84
Self-citationPlasticity of Cancer Cell Invasion—Mechanisms and Implications for Therapy
Boekhorst, V. T., & Friedl, P. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.07.005 · Cited by 100
New therapeutic targets for cancer bone metastasis
Krzeszinski, J. Y., & Wan, Y. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.006 · Cited by 94
Cell Spheroids with Enhanced Aggressiveness to Mimic Human Liver Cancer In Vitro and In Vivo
Jung, H.-R., Kang, H. M., Ryu, J., Kim, D., Noh, K. H., Kim, E., Lee, H., Chung, K., Cho, H., Kim, N.-S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10828-7 · Cited by 88
Hypoxia-active nanoparticles used in tumor theranostic
Wang, Y., Shang, W., Niu, M., Tian, J., & Xu, K. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s196959 · Cited by 82
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Shang, T., Jia, Z., Li, J., Cao, H., Xu, H., Cong, L., Ma, D., Wang, X., & Liu, J. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01684-4 · Cited by 100
“During hypoxia, significant changes occur in non-cancerous components, including increased activation and growth of stromal cells such as stellate cells and cancer-associated fibroblasts (CAFs), as well as an accumulation of stromal elements such as fibrin [19].”
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82
Confeld, M. I., Mamnoon, B., Feng, L., Jensen‐Smith, H. C., Ray, P., Froberg, J., Kim, J., Hollingsworth, M. A., Quadir, M., Choi, Y., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00247 · Cited by 82
Nawaz, M., Fatima, F., Nazarenko, I. A., Ekström, K. M., Murtaza, I., Anees, M., Sultan, A., Neder, L., Camussi, G., Valadi, H., et al. (2016) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1165613 · Cited by 86
Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics
Park, H., Saravanakumar, G., Kim, J., Lim, J., & Kim, W. J. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000834 · Cited by 88
Huang, C., Tan, W., Zheng, J., Zhu, C., Huo, J., & Yang, R. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b08115 · Cited by 82
Zhangyuan, G., Wang, F., Zhang, H., Jiang, R., Tao, X., Yu, D., Jin, K., Yu, W., Liu, Y., Yin, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1052-7 · Cited by 80
Peng, Z., Tong, Z., Ren, Z., Ye, M., & Hu, K. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00665-y · Cited by 91
Early redox activities modulate Xenopus tail regeneration
Ferreira, F., Raghunathan, V. K., Luxardi, G., Zhu, K., & Zhao, M. (2018) · Nature Communications · doi:10.1038/s41467-018-06614-2 · Cited by 89
ITGB3/CD61: a hub modulator and target in the tumor microenvironment.
Zhu, C., Kong, Z., Wang, B., Cheng, W., Wu, A., & Meng, X. (2019) · Europe PMC (PubMed Central) · Cited by 100
Yang, Y. P., Zhu, W., Cheng, L., Cai, R., Yi, X., He, J., Pan, X., Yang, L., Yang, K., Liu, Z., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119971 · Cited by 78
Molecular mediators of peritoneal metastasis in pancreatic cancer
Avula, L. R., Hagerty, B. L., & Alewine, C. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09924-4 · Cited by 83
Sarnella, A., Ferrara, Y., Auletta, L., Albanese, S., Cerchia, L., Alterio, V., Simone, G. D., Supuran, C. T., & Zannetti, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02345-x · Cited by 84
“A characteristic of advanced cancer is the presence of a hypoxic microenvironment, due to an aberrant vascularization and a poor blood supply, driving a lethal phenotype [6].”
BackgroundWei, F., Karges, J., Shen, J., Xie, L., Xiong, K., Zhang, X., Ji, L., & Chao, H. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101509 · Cited by 79
D‐Peptides as Recognition Molecules and Therapeutic Agents
Liu, M., Li, X., Xie, Z., Xie, C., Zhan, C., Hu, X., Shen, Q., Wei, X., Su, B., Wang, J., et al. (2016) · The Chemical Record · doi:10.1002/tcr.201600005 · Cited by 76
Colangelo, T., Polcaro, G., Muccillo, L., D'Agostino, G., Rosato, V., Ziccardi, P., Lupo, A., Mazzoccoli, G., Sabatino, L., & Colantuoni, V. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.11.001 · Cited by 100
Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target
Nakamura, K., Sawada, K., Kobayashi, M., Miyamoto, M., Shimizu, A., Yamamoto, M., Kinose, Y., & Kimura, T. (2019) · Cancers · doi:10.3390/cancers11081147 · Cited by 81
“Hypoxia causes the cells to acquire a more aggressive malignant phenotype that allows them to metastasize [49].”
BackgroundHe, C., Zhang, X., Yan, R., Zhao, P., Chen, Y., Li, M., Chen, C., Fan, T., Lu, Y., Wang, C., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00797k · Cited by 75
Hypoxia: a barricade to conquer the pancreatic cancer
Tan, Z., Xu, J., Zhang, B., Shi, S., Yu, X., & Liang, C. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03444-3 · Cited by 80
Sun, P., Sun, D. S., & Wang, X. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.03.022 · Cited by 73
Liu, J., Tian, L., Zhang, R., Dong, Z., Wang, H., & Liu, Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17684 · Cited by 74
Modelling liver cancer microenvironment using a novel 3D culture system
Hrout, A. A., Cervantes-Gracia, K., Chahwan, R., & Amin, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-11641-7 · Cited by 85
Hermann, D. M., Xin, W., Bähr, M., Giebel, B., & Doeppner, T. R. (2022) · Theranostics · doi:10.7150/thno.73931 · Cited by 83
“The main cause of hypoxia in cancer tissue are proliferating tumor cells growing out from blood vessels, which often have irregular network characteristics with compromised blood supply [1, 8].”
BackgroundThe role of hypoxia on prostate cancer progression and metastasis
Mohamed, O. A. A., Tesen, H. S., Hany, M., Sherif, A., Abdelwahab, M. M., & Elnaggar, M. H. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08251-5 · Cited by 88
“HIFs induce the expression of collagenmodifying enzymes such as prolyl-4-hydroxylase alpha-subunits (P4HA1 and P4HA2) and procollagenlysyl-hydroxylases (PLOD1 and PLOD2), which are essential for collagen synthesis and collagen fibrils synthesis [19].”
BackgroundReciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis
Fregni, G., Quinodoz, M., Möller, E., Vuille, J., Galland, S., Fusco, C., Martin, P., Letovanec, I., Provero, P., Rivolta, C., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.02.017 · Cited by 74
The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
Wang, S., Qiu, Y., & Bai, B. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00614 · Cited by 75
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
Xiang, L., Gilkes, D. M., Hu, H., Luo, W., Bullen, J. W., Liang, H., & Semenza, G. L. (2015) · Oncotarget · doi:10.18632/oncotarget.4190 · Cited by 73
Self-citationFeng, L., Chen, M., Li, R., Zhou, L., Wang, C., Ye, P., Hu, X., Yang, J., Sun, Y., Zhu, Z., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.10.032 · Cited by 72
Li, Z.-L., Wang, Z., Wei, G., Yang, Y., & Wang, X. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i3.267 · Cited by 82
Cheng, N., Bei, Y., Song, Y., Zhang, W., Xu, L., Zhang, W., Yang, N., Bai, X., Shu, Y., & Shen, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114298 · Cited by 73
The role and therapeutic potential of MSC-derived exosomes in osteoarthritis
Bao, C., & He, C. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109002 · Cited by 79
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis
Huang, Y., Liang, C.-Y., Ritz, D., Coelho, R., Septiadi, D., Estermann, M., Cumin, C., Rimmer, N., Schötzau, A., López, M. N., et al. (2020) · eLife · doi:10.7554/elife.59442 · Cited by 80
Kurashige, J., Hasegawa, T., Niida, A., Sugimachi, K., Deng, N., Mima, K., Uchi, R., Sawada, G., Takahashi, Y., Eguchi, H., et al. (2016) · Scientific Reports · doi:10.1038/srep22371 · Cited by 78
Jang, M., Koh, I., Lee, S. J., Cheong, J.-H., & Kim, P. (2017) · Scientific Reports · doi:10.1038/srep41541 · Cited by 69
Bao, Y.-W., Hua, X.-W., Zeng, J., & Wu, F. (2020) · Research · doi:10.34133/2020/9301215 · Cited by 71
Chen, T., Liu, R., Niu, Y., Mo, H., Wang, H., Lu, Y. F., Wang, L., Sun, L., Wang, Y., Tu, K., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04449-2 · Cited by 70
“Increasing amounts of evidence demonstrated that hypoxia is present ubiquitously in solid tumors and plays a crucial role in various biological processes in kinds of malignancies, including HCC [15].”
BackgroundHe, M., Zhang, M., Xu, T., Xue, S., Li, D., Zhao, Y., Zhi, F., & Ding, D. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.02.030 · Cited by 72
Segura-Villalobos, D., Ramírez-Moreno, I. G., Martínez-Aguilar, M., Ibarra-Sánchez, A., Muñoz-Bello, J. O., Anaya‐Rubio, I., Padilla, A., Macías‐Silva, M., Lizano, M., & González‐Espinosa, C. (2022) · Cells · doi:10.3390/cells11030349 · Cited by 78
“ECM deposition also promotes hypoxia and the generation of an immunosuppressive TME and tumor metastasis [235].”
BackgroundRecent Advances of Organ-on-a-Chip in Cancer Modeling Research
Liu, X., Su, Q., Zhang, X., Yang, W., Ning, J., Jia, K., Xin, J., Li, H., Yu, L., Liao, Y., et al. (2022) · Biosensors · doi:10.3390/bios12111045 · Cited by 75
CCN family of proteins: critical modulators of the tumor cell microenvironment
Yeger, H., & Perbal, B. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0346-6 · Cited by 70
A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
Ahmed, E. M., Bandopadhyay, G., Coyle, B., & Grabowska, A. M. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0374-8 · Cited by 70
Yan, X., Zhou, L., Wu, Z., Wang, X., Chen, X., Yang, F., Guo, Y., Wu, M., Chen, Y., Li, W., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.020 · Cited by 69
Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells
Tang, K., Yu, Y., Zhu, L., Xu, P., Chen, J., Ma, J., Zhang, H., Fang, H., Sun, W., Zhou, L., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0932-1 · Cited by 67
Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 83
“In vivo, stromal cells such as fibroblasts and endothelial cells do not remain statically embedded but actively reposition themselves in response to gradients in oxygen, nutrients, and soluble factors [274,275].”
Li, H., Peng, C., Zhu, C., Nie, S., Qian, X., Shi, Z., Shi, M., Yan, L., Ding, X., Zhang, S., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01016-6 · Cited by 76
“Increased desmoplasia and resulting insufficient perfusion are important causes of hypoxia in PC [3, 4].”
Redox regulation and its emerging roles in cancer treatment
Zhang, H., Mao, Z., Kang, Y., Zhang, W., Mei, L., & Ji, X. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214897 · Cited by 69
Ponente, M., Campanini, L., Cuttano, R., Piunti, A., Delledonne, G. A., Coltella, N., Valsecchi, R., Villa, A., Cavallaro, U., Pattini, L., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.87380 · Cited by 70
Intermittent hypoxia and cancer: Undesirable bed partners?
Almendros, I., & Gozal, D. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.08.008 · Cited by 72
Norton, K., Jin, K., & Popel, A. S. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.05.003 · Cited by 70
p53’s Extended Reach: The Mutant p53 Secretome
Pavlakis, E., & Stiewe, T. (2020) · Biomolecules · doi:10.3390/biom10020307 · Cited by 68
Endogenous Stimuli‐Activatable Nanomedicine for Immune Theranostics for Cancer
Wang, W., Jin, Y., Liu, X., Chen, F., Zheng, X., Liu, T., Yang, Y., & Yu, H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100386 · Cited by 70
Li, X., Wang, M., Li, S., Chen, Y., Wang, M., Wu, Z., Sun, X., Yao, L., Dong, H., Song, Y., et al. (2021) · Theranostics · doi:10.7150/thno.57804 · Cited by 73
“Occurring in 90% of solid tumors, hypoxia plays a key role in inducing malignant tumor phenotypes and elevating chemotherapeutic resistance, which has been linked to an increased metastatic potential [5-8].”
BackgroundEffectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles
Li, Z., Guo, Z., Chu, D., Feng, H., Zhang, J., Zhu, L., & Li, J. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1730522 · Cited by 62
“Celastrol, a component of traditional Chinese medicine, has been demonstrated that exhibit potent anti-tumor (Nanjundaiah et al., 2012), anti-inflammation, anti-angiogenesis activity (Hanahan & Weinberg, 2011).”
BackgroundFukumoto, I., Kikkawa, N., Matsushita, R., Kato, M., Kurozumi, A., Nishikawa, R., Goto, Y., Koshizuka, K., Hanazawa, T., Enokida, H., et al. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.120 · Cited by 64
Zhu, L., Xi, P.-W., Li, X., Sun, X., Zhou, W., Xia, T., Shi, L., Hu, Y., Ding, Q., & Wei, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1111-5 · Cited by 66
Fluid shear stress facilitates prostate cancer metastasis through Piezo1-Src-YAP axis
Kim, O., Choi, Y. W., Park, J., Hong, S. A., Hong, M. E., Chang, I. H., & Lee, H. J. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120936 · Cited by 75
Interplay Between Extracellular Matrix Remodeling and Angiogenesis in Tumor Ecosystem
Siddhartha, R., & Garg, M. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0595 · Cited by 81
Regulation of Hyaluronan Synthesis in Vascular Diseases and Diabetes
Moretto, P., Karousou, E. G., Viola, M., Caon, I., D’Angelo, M. L., Luca, G. D., Passi, A. G., & Vigetti, D. (2015) · Journal of Diabetes Research · doi:10.1155/2015/167283 · Cited by 69
Increased extracellular matrix density disrupts E-cadherin/β-catenin complex in gastric cancer cells
Jang, M., Koh, I., Lee, J. E., Lim, J. Y., Cheong, J.-H., & Kim, P. (2018) · Biomaterials Science · doi:10.1039/c8bm00843d · Cited by 64
Pei, P., Shen, W., Zhou, H., Sun, Y., Zhong, J., Liu, T., & Yang, K. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101144 · Cited by 65
Xu, F., Wang, M., Dotse, E., Chow, K. T., & Lo, P. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202404561 · Cited by 75
Radiofrequency ablation: mechanisms and clinical applications
Wu, J., Zhou, Z., Huang, Y., Deng, X., Zheng, S., He, S., Huang, G., Hu, B., Shi, M., Liao, W., et al. (2024) · MedComm · doi:10.1002/mco2.746 · Cited by 80
“112,114 Hypoxia causes the autocrine activation of CD95 on colorectal tumor cells, thereby promoting local invasion and accelerated metastasis outgrowth in the hypoxic transition zone following RFA.”
BackgroundPei, S., Xu, Y., Wang, H., Zhang, H., Zhou, B., Zhang, D., & Lin, D. (2015) · BMC Cancer · doi:10.1186/s12885-015-1960-z · Cited by 66
Wu, C., Zhuang, Y., Jiang, S., Tian, F., Teng, Y., Chen, X., Zheng, P.-Q., Liu, S., Zhou, J., Wu, J., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.01.005 · Cited by 63
Sethuraman, A., Brown, M., Krutilina, R., Wu, Z.-H., Seagroves, T. N., Pfeffer, L. M., & Fan, M. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1046-3 · Cited by 63
COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer
Jiang, X., Wu, M., Xu, X., Zhang, L., Huang, Y., Xu, Z., He, K., Wang, H., Wang, H., & Teng, L. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10548 · Cited by 62
Zhu, K., Wang, L., Xiao, Y., Zhang, X., You, G., Chen, Y., Wang, Q., Zhao, L., Zhou, H., & Chen, G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02606-1 · Cited by 71
“…manner and consume large amounts of oxygen [149, 150], which results in a tumor microenvironment (TME) [151–153] that is characterized by hypoxia accompanied by weak acids and high levels of H 2 O 2 , and it directly contributes to cancer cell metastasis, invasion, and angiogenesis [154, 155].”
BackgroundTwo in one: merging photoactivated chemotherapy and photodynamic therapy to fight cancer
Kuznetsov, K. M., Cariou, K., & Gasser, G. (2024) · Chemical Science · doi:10.1039/d4sc04608k · Cited by 65
Jia, X.-H., Feng, G.-W., Wang, Z.-L., Du, Y., Shen, C., Hui, H., Peng, D., Li, Z.-J., Kong, D.-L., & Tian, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8064 · Cited by 62
“Currently, we do not fully understand how macrophages initially switch from being antitumor to protumorigenic at the onset of disease [5].”
In-depth proteomic profiling of the uveal melanoma secretome
Angi, M., Kalirai, H., Prendergast, S., Simpson, D. M., Hammond, D. E., Madigan, M. C., Beynon, R. J., & Coupland, S. E. (2016) · Oncotarget · doi:10.18632/oncotarget.10418 · Cited by 64
Errarte, P., Larrinaga, G., & Lopez, J. I. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2019.09.004 · Cited by 71
“Interactions between these different cell types generate the remodeling of the ECM, a key phenomenon for tumor development and metastasis [38].”
BackgroundJiao, Y., Zhang, L., Gao, X., Si, W., & Duan, C. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201915040 · Cited by 64
Campillo, N., Falcones, B., Otero, J., Colina, R., Gozal, D., Navajas, D., Farré, R., & Almendros, I. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00043 · Cited by 66
Designing Hypoxia‐Responsive Nanotheranostic Agents for Tumor Imaging and Therapy
Zhou, H., Qin, F., & Chen, C. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001277 · Cited by 65
Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)
Naser, R., Fakhoury, I., El‑Fouani, A., Abi‑Habib, R., & El‑Sibai, M. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5471 · Cited by 61
Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment
Elkashef, S. M., Allison, S. J., Sadiq, M., Basheer, H. A., Morais, G. R., Loadman, P. M., Pors, K., & Falconer, R. A. (2016) · Scientific Reports · doi:10.1038/srep33026 · Cited by 66
Zhang, J., Zhang, J., Xu, S., Zhang, X., Wang, P., Wu, H., Xia, B., Zhang, G., Lei, B., Wan, L., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487162 · Cited by 61
A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer
Ruan, T., Liu, W., Tao, K., & Wu, C. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s239336 · Cited by 60
Hypoxic pathobiology of breast cancer metastasis
Schito, L., & Rey, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.004 · Cited by 67
Eriksson, J., Joncour, V. L., Nummela, P., Jahkola, T., Virolainen, S., Laakkonen, P., Saksela, O., & Hölttä, E. (2016) · Oncotarget · doi:10.18632/oncotarget.7604 · Cited by 68
Metadata
- Authors
- Gilkes, D. M., Semenza, G. L., & Wirtz, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Wirtz, Denis
- Venue
- Nature Reviews Cancer
- Published
- 2014-05-15
- Volume
- 14
- Issue
- 6
- Pages
- 430-439
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4283800
- OpenAlex
- W2069518226
- Cited by
- 1,520
- References
- 209
- Citations by year
- 2026: 99 · 2025: 129 · 2024: 149 · 2023: 151 · 2022: 175 · 2021: 192 · 2020: 164 · 2019: 132 · 2018: 106 · 2017: 95 · 2016: 75 · 2015: 41 · 2014: 9
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U54CA143868, R01CA174388, K99CA181352)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- tumor hypoxia, extracellular matrix, tumour metastasis, tumor microenvironment, stromal cells, tumor cell motility, tumor cell proliferation
- MeSH terms
- Hypoxia, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.